33 filings
8-K
ABSI
Absci Corp
21 Mar 24
Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results
7:31am
8-K
ABSI
Absci Corp
28 Feb 24
Absci Announces Proposed Public Offering of Common Stock
4:06pm
8-K
ABSI
Absci Corp
27 Feb 24
Results of Operations and Financial Condition
4:45pm
8-K
ABSI
Absci Corp
8 Jan 24
Absci Corporation 2024 All Rights Reserved 42ND JP Morgan Healthcare Conference
7:08am
8-K
ABSI
Absci Corp
20 Dec 23
Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline
8:30am
8-K
vlpxne3w4bpubcdg8
7 Dec 23
Departure of Directors or Certain Officers
8:30am
8-K
o81jtgg wi3xru
4 Dec 23
Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate
7:31am
8-K
uusaerjn0ovkamp5
14 Nov 23
Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results
4:40pm
8-K
n6r cb1gr6
5 Sep 23
Other Events
8:15am
8-K
dsb3vxif87q8t1j1fpj1
17 Aug 23
Departure of Directors or Certain Officers
5:02pm
8-K
7f9cj0c5g
14 Aug 23
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
8:13am
8-K
vfk lzeb9
16 Jun 23
Entry into a Material Definitive Agreement
4:23pm
8-K
fpnoiyz99v2rj3pcor
6 Jun 23
Departure of Directors or Certain Officers
4:08pm
8-K
tk45onli
15 May 23
Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results
4:08pm
8-K
hwn4x4yspvzxdn6pk4i
30 Mar 23
Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
4:10pm
8-K
hn9oc3fhj
10 Mar 23
Regulation FD Disclosure
2:32pm
8-K
hx5wk
16 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:07pm
8-K
krih34
9 Nov 22
Absci Reports Third Quarter 2022 Financial Results
9:18am
8-K
ufwf7duomiw
2 Nov 22
Absci Welcomes Meta Senior Executive to Board of Directors
4:06pm
8-K
35hf8uk8t0oyy7t8x6
4 Oct 22
Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer
4:09pm